---
figid: PMC7851129__41416_2020_1119_Fig2_HTML
figtitle: 'SUMO pathway in pancreatic cancer: insights and inhibition'
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC7851129
filename: 41416_2020_1119_Fig2_HTML.jpg
figlink: pmc/articles/PMC7851129/figure/Fig2/
number: F2
caption: The figure depicts inhibitors of the pathway, which block the SUMO-activating
  enzyme or UBC9. Furthermore, peptidomimetic or non-peptidomimetic inhibitors of
  the interaction of SUMOylated proteins with readers of the SUMO code using the SUMO-interacting
  motif (SIM) are shown.
papertitle: 'The SUMO pathway in pancreatic cancer: insights and inhibition.'
reftext: Christian Schneeweis, et al. Br J Cancer. 2021 Feb 2;124(3):531-538.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8671319
figid_alias: PMC7851129__F2
figtype: Figure
organisms_ner:
- NA
redirect_from: /figures/PMC7851129__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7851129__41416_2020_1119_Fig2_HTML.html
  '@type': Dataset
  description: The figure depicts inhibitors of the pathway, which block the SUMO-activating
    enzyme or UBC9. Furthermore, peptidomimetic or non-peptidomimetic inhibitors of
    the interaction of SUMOylated proteins with readers of the SUMO code using the
    SUMO-interacting motif (SIM) are shown.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ginkgolic acid
  - anacardic acid
  - kerriamycin B
---
